Centrum and Rinvoq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Centrum (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e) and Rinvoq (upadacitinib). Common drug interactions include pneumonia among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Centrum and Rinvoq. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Centrum?

Centrum has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 34,686 Centrum users. Check the latest studies of Centrum.

What is Rinvoq?

Rinvoq has active ingredients of upadacitinib. eHealthMe is studying from 47,375 Rinvoq users. Check the latest studies of Rinvoq.



On Jul, 06, 2026

19 people who take Centrum and Rinvoq together, and have interactions are studied.

Centrum and Rinvoq drug interactions.

What are the common drug interactions of Centrum and Rinvoq, by gender? *:

female:

  1. Pneumonia
  2. Upper limb fracture
  3. Back pain
  4. Neck pain
  5. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  6. Air embolism
  7. Asthma
  8. Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Drug ineffective

male:

  1. Arthralgia (joint pain)
  2. Cough
  3. Pain
  4. Peripheral swelling
  5. Skin ulcer
  6. Upper-airway cough syndrome

What are the common drug interactions of Centrum and Rinvoq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Foot deformity (functional disability of foot)
  2. Mobility decreased (ability to move is reduced)

40-49:

n/a

50-59:

  1. Air embolism
  2. Asthma
  3. Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Headache (pain in head)
  6. Oxygen saturation decreased
  7. Pneumonia
  8. Arthralgia (joint pain)
  9. Forearm fracture (fracture in between wrist to elbow)
  10. Lower limb fracture

60+:

  1. Arthralgia (joint pain)
  2. Pain
  3. Swelling
  4. Upper limb fracture
  5. Wrist fracture
  6. Asthenia (weakness)
  7. Balance disorder
  8. Cardiomegaly (increased size of heart than normal)
  9. Cough
  10. Hypertension (high blood pressure)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 84.21%
  2. Pain: 4 people, 21.05%
  3. Swelling: 2 people, 10.53%
  4. Stomatitis (inflammation of mucous membrane of mouth): 2 people, 10.53%
  5. Sleep Disorder: 2 people, 10.53%
  6. Gastric Disorder (disease of stomach): 2 people, 10.53%
  7. High Blood Cholesterol: 2 people, 10.53%
  8. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 5.26%
  9. Hair Disorder: 1 person, 5.26%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Centrum and Rinvoq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Centrum and Rinvoq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Centrum:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rinvoq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Centrum and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rinvoq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e and upadacitinib (the active ingredients of Centrum and Rinvoq, respectively), and Centrum and Rinvoq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: